207 related articles for article (PubMed ID: 25596695)
1. [Suspected dihydropyrimidine dehydrogenase deficiency in a patient receiving capecitabine as adjuvant chemotherapy after colon resection].
Nagai K; Okuda Y; Ohara Y; Yamamoto M
Gan To Kagaku Ryoho; 2015 Jan; 42(1):127-9. PubMed ID: 25596695
[TBL] [Abstract][Full Text] [Related]
2. [A case in which dihydropyrimidine dehydrogenase deficiency was strongly suspected during adjuvant chemotherapy with capecitabine for colon cancer].
Toshima T; Kodera M; Yamashita Y; Oishi M; Seshimo K; Yamamura M; Kato H; Ikeda H; Mizuno K
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1549-52. PubMed ID: 24231713
[TBL] [Abstract][Full Text] [Related]
3. [Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency].
Hooiveld EA; van Kuilenburg AB; Haanen JB; Westermann AM
Ned Tijdschr Geneeskd; 2004 Mar; 148(13):626-8. PubMed ID: 15083629
[TBL] [Abstract][Full Text] [Related]
4. [Severe capecitabine-associated toxicity in a patient carrying a mutation in the dihydropyrimidine dehydrogenase gen].
González-Haba E
Farm Hosp; 2012; 36(6):554-5. PubMed ID: 23461455
[No Abstract] [Full Text] [Related]
5. Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine.
Saif MW; Elfiky A; Diasio R
Clin Colorectal Cancer; 2006 Sep; 6(3):219-23. PubMed ID: 17026792
[TBL] [Abstract][Full Text] [Related]
6. Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review.
Hagiwara Y; Yamamoto Y; Inagaki Y; Tomisaki R; Tsuji M; Fukuda S; Fukuda S; Onoda T; Suzuki H; Niisato Y; Tange Y; Ikeda N; Yamada K; Kobayashi M; Akutsu D; Yamada T; Moriwaki T; Narasaka T; Suzuki H; Tsuchiya K
Intern Med; 2022 Aug; 61(16):2449-2455. PubMed ID: 35110482
[TBL] [Abstract][Full Text] [Related]
7. [A case of relapsed colon cancer successfully treated by capecitabine].
Hashimoto T; Yokoyama M; Kimura S; Usuba O; Toyono M
Gan To Kagaku Ryoho; 2013 Apr; 40(4):523-7. PubMed ID: 23848025
[TBL] [Abstract][Full Text] [Related]
8. [Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiency].
Coursier S; Martelet S; Guillermet A; Emptoz J; Villier C; Bontemps H
Gastroenterol Clin Biol; 2010 Mar; 34(3):218-23. PubMed ID: 20219304
[TBL] [Abstract][Full Text] [Related]
9. A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient.
Blasco H; Boisdron-Celle M; Bougnoux P; Calais G; Tournamille JF; Ciccolini J; Autret-Leca E; Le Guellec C
Br J Clin Pharmacol; 2008 Jun; 65(6):966-70. PubMed ID: 18294332
[No Abstract] [Full Text] [Related]
10. [Dihydropyrimidine dehydrogenase deficiency causes severe adverse effects of capecitabine].
Inoue H; Sato Y; Shintani S; Tanabe H; Bamba H; Komai Y; Nakamura T; Imai T; Andou A
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(3):290-298. PubMed ID: 29526981
[TBL] [Abstract][Full Text] [Related]
11. [Resection for the treatment of bleeding caused by ovarian metastasis after hepatectomy for metachronous liver metastasis from sigmoid colon cancer].
Kobayashi H; Uetake H; Iida S; Ishikawa T; Ishiguro M; Okazaki S; Kikuchi A; Baba H; Takahashi H; Iwata N; Sugihara K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1915-7. PubMed ID: 24393964
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene.
Shahrokni A; Rajebi MR; Harold L; Saif MW
JOP; 2009 Mar; 10(2):215-20. PubMed ID: 19287123
[TBL] [Abstract][Full Text] [Related]
13. [Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer].
Matsuda C; Tamagawa H; Nishikawa K; Deguchi T; Kawata J; Iwase K; Takagi M; Fukui A; Nezu R; Tanaka Y
Gan To Kagaku Ryoho; 2013 Mar; 40(3):327-30. PubMed ID: 23507593
[TBL] [Abstract][Full Text] [Related]
14. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases.
Cordier PY; Nau A; Ciccolini J; Oliver M; Mercier C; Lacarelle B; Peytel E
Cancer Chemother Pharmacol; 2011 Sep; 68(3):823-6. PubMed ID: 21553285
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine-induced acute myeloid leukaemia.
Tansley S; Gibbons S
N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
[No Abstract] [Full Text] [Related]
16. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
[TBL] [Abstract][Full Text] [Related]
18. Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.
Disel U; Gürkut O; Abali H; Kaleağasi H; Mertsoylu H; Ozyilkan O; Saif MW
Cutan Ocul Toxicol; 2010 Jun; 29(2):140-2. PubMed ID: 20298142
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy with capecitabine for colon cancer - a case series].
Kuji M; Masuko H; Yamagami H; Matsumoto S; Tanioka T; Takahashi S; Ishizu H; Takahashi M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1752-4. PubMed ID: 25731318
[TBL] [Abstract][Full Text] [Related]
20. Toxicity Associated with Capecitabine in Patients Suffering from Dihydropyrimidine Dehydrogenase Deficiency.
Bermejo-Pérez MJ; Galeote-Miguel AM; Rodelo-Haad LE; Alés-Díaz I; Durán-Ogalla G; Benavides-Orgaz M
Chemotherapy; 2014; 60(5-6):353-5. PubMed ID: 26330092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
